TickerTain — Make Analysis Fun Again

▶ 0:35 · $COLOSSAL-BIOSCIENCES · $12B De-Extinction Company Colossal Biosciences Spun Out $3.8B Astromech

episode shorts · 1

Woolly Mice, Dire Wolves & a $3.8B AI Spinout: Inside $12B Colo…

now playing · $COLOSSAL-BIOSCIENCES

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Colossal raises $400M round, 2x oversubscribed, plans more capital

The last $400M round was originally targeted at $200M but was 2x oversubscribed; Lamm says every round has been >2x oversubscribed, signaling strong investor demand and that the c…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Lamm calls Colossal one of world's most undervalued companies after $400M oversubscribed round

Colossal's vertical integration across genome engineering, artificial wombs, and DNA synthesis at planetary scale creates a civilization-tech platform with applications from de-ex…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Colossal raises $400M at $12B valuation, 2x oversubscribed, plans more capital

Strong investor demand validates the platform; $635M total raised with last round targeting $200M but closing at $400M, and Lamm expects further raises to fund the expanding pipel…

$ASTROMECHbullish· mediumben lamm

Colossal spinout Astromech uses evolutionary AI to find cancer-resistance targets

Astromech applies a focused AI model to evolutionary genomics — leveraging Colossal's massive elephant dataset — to identify conserved cancer-resistance mechanisms (e.g., p53 over…

$VIAGENbullish· mediumben lamm

Colossal acquires Viagen for 80% cloning efficiency vs 2% industry standard

Vertical integration via Viagen acquisition gives Colossal best-in-class cloning infrastructure (80% efficiency vs 2% typical), a critical bottleneck for endangered-species produc…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Gene-drive screwworm eradication could save taxpayers $1.5B and 8 years vs current plan

Colossal's gene-drive technology can eradicate the New World screwworm in 6-7 months versus the USDA's 8-year, $1.5B chemical program, representing a massive government-contract o…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Exceeding edit-scale roadmap: hundreds of multiplex edits now, thousands targeted

Technical execution far surpassing early milestones — told 5-7 edits in 5 years would be great, now doing hundreds and pushing a new construct for thousands of simultaneous edits,…

←

▶ 0:35 · $COLOSSAL-BIOSCIENCES · $12B De-Extinction Company Colossal Biosciences Spun Out $3.8B Astromech

episode shorts · 1

Woolly Mice, Dire Wolves & a $3.8B AI Spinout: Inside $12B Colo…

now playing · $COLOSSAL-BIOSCIENCES

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Colossal raises $400M round, 2x oversubscribed, plans more capital

The last $400M round was originally targeted at $200M but was 2x oversubscribed; Lamm says every round has been >2x oversubscribed, signaling strong investor demand and that the c…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Lamm calls Colossal one of world's most undervalued companies after $400M oversubscribed round

Colossal's vertical integration across genome engineering, artificial wombs, and DNA synthesis at planetary scale creates a civilization-tech platform with applications from de-ex…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Colossal raises $400M at $12B valuation, 2x oversubscribed, plans more capital

Strong investor demand validates the platform; $635M total raised with last round targeting $200M but closing at $400M, and Lamm expects further raises to fund the expanding pipel…

$ASTROMECHbullish· mediumben lamm

Colossal spinout Astromech uses evolutionary AI to find cancer-resistance targets

Astromech applies a focused AI model to evolutionary genomics — leveraging Colossal's massive elephant dataset — to identify conserved cancer-resistance mechanisms (e.g., p53 over…

$VIAGENbullish· mediumben lamm

Colossal acquires Viagen for 80% cloning efficiency vs 2% industry standard

Vertical integration via Viagen acquisition gives Colossal best-in-class cloning infrastructure (80% efficiency vs 2% typical), a critical bottleneck for endangered-species produc…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Gene-drive screwworm eradication could save taxpayers $1.5B and 8 years vs current plan

Colossal's gene-drive technology can eradicate the New World screwworm in 6-7 months versus the USDA's 8-year, $1.5B chemical program, representing a massive government-contract o…

$COLOSSAL-BIOSCIENCESbullish· highben lamm

Exceeding edit-scale roadmap: hundreds of multiplex edits now, thousands targeted

Technical execution far surpassing early milestones — told 5-7 edits in 5 years would be great, now doing hundreds and pushing a new construct for thousands of simultaneous edits,…